Terlipressin

An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.

Also Known As:

Glipressin; Gly-Gly-Gly-8-Lys-vasopressin; Glycylpressin; Glypressin; N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin; Remestyp; TGLVP; Terlypressin; Triglycyl Lysine Vasopressin; Triglycyl-(8-lysine)vasopressin; Triglycylvasopressin; Vasopressin, tri-Gly-8-Lys-; Gly Gly Gly 8 Lys vasopressin; tri-Gly-8-Lys- Vasopressin; N-(N- (N- glycylglycyl)glycyl)- L- lysinevasopressin

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Pituitary Hormones: 601
      - Posterior Pituitary Hormones: 176
        Vasopressins: 9692
        Lypressin: 123
        Terlipressin: 750
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Vasopressins: 9692
        Lypressin: 123
        Terlipressin: 750
- Peptides: 82426
  - Neuropeptides: 6772
    - Vasopressins: 9692
      - Lypressin: 123
        Terlipressin: 750
  - Peptide Hormones: 1347
    - Pituitary Hormones: 601
      - Posterior Pituitary Hormones: 176
        Vasopressins: 9692
        Lypressin: 123
        Terlipressin: 750
  - Oligopeptides: 519
    - Vasopressins: 9692
      - Lypressin: 123
        Terlipressin: 750

Claudia Tüller Selected Research

Claudia Tüller Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure